Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mothaffar F Rimawi

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Current Problems in Cancer|November 15, 2016
Metastatic human epidermal growth factor receptor 2-positive breast cancer: Management, challenges, and future directionsMohsin Soleja, Mothaffar F Rimawi
JCO Oncology Practice|October 7, 2021
Breast Cancer Prevention: Where Are We?Julie R Nangia, Mothaffar F Rimawi
Nature Reviews. Clinical Oncology|February 15, 2012
Breast Cancer: Blocking both driver and escape pathways improves outcomesMothaffar F Rimawi, C Kent Osborne
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Aromatase inhibitor adverse effects: are we sweeping them under the rug?Polly Niravath, Mothaffar F Rimawi, C Kent Osborne
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Resistance to Anti-HER2 Therapies in Breast CancerMothaffar F Rimawi, Carmine De Angelis, Rachel Schiff
Annual Review of Medicine|January 15, 2015
Targeting HER2 for the treatment of breast cancerMothaffar F Rimawi, Rachel Schiff, C Kent Osborne
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2022
Elacestrant and the Promise of Oral SERDsKatherine G Sanchez, Julie R Nangia, Rachel Schiff, et al.
Breast Cancer Research and Treatment|September 13, 2021
Management of hormone receptor-positive, human epidermal growth factor 2-negative metastatic breast cancerJason A Mouabbi, C Kent Osborne, Rachel Schiff, et al.
Breast Cancer Research and Treatment|February 23, 2017
Retrospective review of genomic testing in breast cancer: Does it improve outcome?Grady M Gastelum, Cyrus Iqbal, Susan G Hilsenbeck, et al.
Clinical Breast Cancer|March 3, 2012
Jejunal intussusception due to malignant phyllodes tumor of the breastMehmet Asim Bilen, Rodolfo Laucirica, Mothaffar F Rimawi, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Current Problems in Cancer|November 15, 2016
Metastatic human epidermal growth factor receptor 2-positive breast cancer: Management, challenges, and future directionsMohsin Soleja, Mothaffar F Rimawi
JCO Oncology Practice|October 7, 2021
Breast Cancer Prevention: Where Are We?Julie R Nangia, Mothaffar F Rimawi
Nature Reviews. Clinical Oncology|February 15, 2012
Breast Cancer: Blocking both driver and escape pathways improves outcomesMothaffar F Rimawi, C Kent Osborne
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Aromatase inhibitor adverse effects: are we sweeping them under the rug?Polly Niravath, Mothaffar F Rimawi, C Kent Osborne
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Resistance to Anti-HER2 Therapies in Breast CancerMothaffar F Rimawi, Carmine De Angelis, Rachel Schiff
Annual Review of Medicine|January 15, 2015
Targeting HER2 for the treatment of breast cancerMothaffar F Rimawi, Rachel Schiff, C Kent Osborne
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2022
Elacestrant and the Promise of Oral SERDsKatherine G Sanchez, Julie R Nangia, Rachel Schiff, et al.
Breast Cancer Research and Treatment|September 13, 2021
Management of hormone receptor-positive, human epidermal growth factor 2-negative metastatic breast cancerJason A Mouabbi, C Kent Osborne, Rachel Schiff, et al.
Breast Cancer Research and Treatment|February 23, 2017
Retrospective review of genomic testing in breast cancer: Does it improve outcome?Grady M Gastelum, Cyrus Iqbal, Susan G Hilsenbeck, et al.
Clinical Breast Cancer|March 3, 2012
Jejunal intussusception due to malignant phyllodes tumor of the breastMehmet Asim Bilen, Rodolfo Laucirica, Mothaffar F Rimawi, et al.
Pageof 8